vs
FIRST BANCORP（FBP）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
FIRST BANCORP的季度营收约是REPLIGEN CORP的1.3倍（$257.2M vs $197.9M），FIRST BANCORP净利率更高（33.9% vs 6.7%，领先27.2%），REPLIGEN CORP同比增速更快（13.6% vs 6.5%），FIRST BANCORP自由现金流更多（$103.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 5.6%）
第一中西部银行总部位于美国伊利诺伊州芝加哥市，地处奥黑尔机场东侧，其前身可追溯至伊利诺伊州乔利埃特市。发展至今，该行服务范围覆盖芝加哥众多郊区，包括印第安纳州西北部、伊利诺伊州南部、威斯康星州东南部以及含爱荷华州在内的四城地区，是美国规模最大的银行机构之一。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FBP vs RGEN — 直观对比
营收规模更大
FBP
是对方的1.3倍
$197.9M
营收增速更快
RGEN
高出7.1%
6.5%
净利率更高
FBP
高出27.2%
6.7%
自由现金流更多
FBP
多$85.6M
$17.6M
两年增速更快
RGEN
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $257.2M | $197.9M |
| 净利润 | $87.1M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 41.7% | 9.0% |
| 净利率 | 33.9% | 6.7% |
| 营收同比 | 6.5% | 13.6% |
| 净利润同比 | 15.1% | 143.9% |
| 每股收益（稀释后） | $0.55 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBPRGEN
| Q4 25 | $257.2M | $197.9M | ||
| Q3 25 | $248.7M | $188.8M | ||
| Q2 25 | $246.8M | $182.4M | ||
| Q1 25 | $248.1M | $169.2M | ||
| Q4 24 | $241.5M | $174.1M | ||
| Q3 24 | $234.6M | $154.9M | ||
| Q2 24 | $231.7M | $154.1M | ||
| Q1 24 | $230.5M | $151.3M |
净利润FBPRGEN
| Q4 25 | $87.1M | $13.3M | ||
| Q3 25 | $100.5M | $14.9M | ||
| Q2 25 | $80.2M | $14.9M | ||
| Q1 25 | $77.1M | $5.8M | ||
| Q4 24 | $75.7M | $-30.3M | ||
| Q3 24 | $73.7M | $-654.0K | ||
| Q2 24 | $75.8M | $3.3M | ||
| Q1 24 | $73.5M | $2.1M |
毛利率FBPRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率FBPRGEN
| Q4 25 | 41.7% | 9.0% | ||
| Q3 25 | 42.7% | 8.9% | ||
| Q2 25 | 41.7% | 7.6% | ||
| Q1 25 | 40.4% | 3.9% | ||
| Q4 24 | 39.8% | -17.7% | ||
| Q3 24 | 41.1% | -5.1% | ||
| Q2 24 | 43.8% | 1.0% | ||
| Q1 24 | 42.3% | 1.3% |
净利率FBPRGEN
| Q4 25 | 33.9% | 6.7% | ||
| Q3 25 | 40.4% | 7.9% | ||
| Q2 25 | 32.5% | 8.2% | ||
| Q1 25 | 31.1% | 3.4% | ||
| Q4 24 | 31.4% | -17.4% | ||
| Q3 24 | 31.4% | -0.4% | ||
| Q2 24 | 32.7% | 2.2% | ||
| Q1 24 | 31.9% | 1.4% |
每股收益（稀释后）FBPRGEN
| Q4 25 | $0.55 | $0.24 | ||
| Q3 25 | $0.63 | $0.26 | ||
| Q2 25 | $0.50 | $0.26 | ||
| Q1 25 | $0.47 | $0.10 | ||
| Q4 24 | $0.46 | $-0.55 | ||
| Q3 24 | $0.45 | $-0.01 | ||
| Q2 24 | $0.46 | $0.06 | ||
| Q1 24 | $0.44 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $290.0M | $542.2M |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $19.1B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FBPRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务FBPRGEN
| Q4 25 | $290.0M | $542.2M | ||
| Q3 25 | $290.0M | $537.9M | ||
| Q2 25 | $320.0M | — | ||
| Q1 25 | $331.1M | — | ||
| Q4 24 | $561.7M | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FBPRGEN
| Q4 25 | $2.0B | $2.1B | ||
| Q3 25 | $1.9B | $2.1B | ||
| Q2 25 | $1.8B | $2.1B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.7B | $2.0B | ||
| Q3 24 | $1.7B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $2.0B |
总资产FBPRGEN
| Q4 25 | $19.1B | $2.9B | ||
| Q3 25 | $19.3B | $2.9B | ||
| Q2 25 | $18.9B | $2.9B | ||
| Q1 25 | $19.1B | $2.9B | ||
| Q4 24 | $19.3B | $2.8B | ||
| Q3 24 | $18.9B | $2.8B | ||
| Q2 24 | $18.9B | $2.9B | ||
| Q1 24 | $18.9B | $2.8B |
负债/权益比FBPRGEN
| Q4 25 | 0.15× | 0.26× | ||
| Q3 25 | 0.15× | 0.26× | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | 0.34× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $107.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $103.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 40.1% | 8.9% |
| 资本支出强度资本支出/营收 | 1.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.23× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $437.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流FBPRGEN
| Q4 25 | $107.3M | $25.7M | ||
| Q3 25 | $137.6M | $48.1M | ||
| Q2 25 | $95.4M | $28.6M | ||
| Q1 25 | $108.2M | $15.0M | ||
| Q4 24 | $96.8M | $39.2M | ||
| Q3 24 | $118.0M | $49.3M | ||
| Q2 24 | $71.1M | $42.2M | ||
| Q1 24 | $118.2M | $44.7M |
自由现金流FBPRGEN
| Q4 25 | $103.2M | $17.6M | ||
| Q3 25 | $134.8M | $43.4M | ||
| Q2 25 | $92.8M | $21.5M | ||
| Q1 25 | $106.7M | $11.4M | ||
| Q4 24 | $95.2M | $33.6M | ||
| Q3 24 | $115.4M | $42.3M | ||
| Q2 24 | $69.4M | $37.4M | ||
| Q1 24 | $114.1M | $36.4M |
自由现金流率FBPRGEN
| Q4 25 | 40.1% | 8.9% | ||
| Q3 25 | 54.2% | 23.0% | ||
| Q2 25 | 37.6% | 11.8% | ||
| Q1 25 | 43.0% | 6.8% | ||
| Q4 24 | 39.4% | 19.3% | ||
| Q3 24 | 49.2% | 27.3% | ||
| Q2 24 | 30.0% | 24.3% | ||
| Q1 24 | 49.5% | 24.0% |
资本支出强度FBPRGEN
| Q4 25 | 1.6% | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 1.1% | 3.9% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 0.7% | 3.2% | ||
| Q3 24 | 1.1% | 4.5% | ||
| Q2 24 | 0.7% | 3.1% | ||
| Q1 24 | 1.8% | 5.5% |
现金转化率FBPRGEN
| Q4 25 | 1.23× | 1.93× | ||
| Q3 25 | 1.37× | 3.23× | ||
| Q2 25 | 1.19× | 1.92× | ||
| Q1 25 | 1.40× | 2.57× | ||
| Q4 24 | 1.28× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 0.94× | 12.70× | ||
| Q1 24 | 1.61× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBP
| Consumer Retail Banking Segment | $171.5M | 67% |
| Commercial And Corporate Segment | $46.9M | 18% |
| Mortgage Banking Segment | $22.4M | 9% |
| Virgin Islands Operations Segment | $18.6M | 7% |
RGEN
暂无分部数据
